![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 6, 4298-4304, February 11, 2000
From the Departments of Cell and Molecular Biology, Scripps Research Institute, La Jolla, California 92037
| |
ABSTRACT |
|---|
|
|
|---|
Adenovirus, a respiratory virus with a
double-stranded DNA genome, replicates in the nuclei of mammalian
cells. We have developed a cytosol-dependent in
vitro assay utilizing adenovirus nucleocapsids to examine the
requirements for adenovirus docking to the nuclear pore complex and for
DNA import into the nucleus. Our assay reveals that adenovirus DNA
import is blocked by a competitive excess of classical protein nuclear
localization sequences and other inhibitors of nuclear protein import
and indicates that this process is dependent on hsc70. Previous work
revealed that the hexon (coat) protein of adenovirus is the only major
protein on the surface of the adenovirus nucleocapsid that docks at the
nuclear pore complex. This, together with our finding that in
vitro nuclear import of hexon is inhibited by an excess of
classical nuclear localization sequences, suggests a role for the hexon
protein in adenovirus DNA import. However, recombinant transport
factors that are sufficient for hexon import in permeabilized cells do not support DNA import, indicating that there are other as yet unidentified factors required for this process.
Proteins are imported into the nucleus through aqueous channels
that span the nuclear envelope called nuclear pore complexes (NPCs).1 Whereas ions and
molecules less than ~20-40 kDa can diffuse passively through the
NPC, larger proteins are transported by saturable pathways that are
energy- and signal-dependent. The classical signals that
specify nuclear protein import (nuclear localization sequences (NLSs))
are short stretches of amino acids rich in basic residues, although
other classes of NLSs have been described recently (1, 2). The
transport of NLS-bearing proteins into the nucleus requires the
participation of soluble cytosolic factors (3). The advent of a
cytosol-dependent in vitro assay for nuclear
import (3) has led to the identification of a number of these factors (4), namely importin- Most viruses that replicate in the nucleus must use the NPC to
introduce their genome into the nucleoplasm. Although it is known that
the gated channel of the NPC can expand up to ~25 nm in diameter to
allow signal-mediated transport (11), this is still considerably
smaller than the diameters of many viruses known to replicate in the
nucleus. For example, the diameters of SV40, adenovirus, and
herpesvirus are 45-50, 60-90, and 120-200 nm, respectively.
Enveloped viruses such as human immunodeficiency virus and influenza
manage to circumvent the physical barrier of the NPC by releasing the
genome from their large capsids during entry into the cytoplasm. The
genome is subsequently transported through the NPC as a flexible
protein-nucleic acid complex that appears to utilize a classical
NLS-mediated pathway (12, 13). Most non-enveloped viruses must undergo
restructuring for the import of their genomes into the nucleus. Both
the DNA and associated capsid proteins of SV40 are transported into the
nucleus after infection of cells, but the structural state of the
nucleocapsid during import has not yet been characterized (14).
However, the DNA viruses such as adenovirus, baculovirus, and
hepadnavirus all appear to only partially uncoat at various stages of
entry into the host cell (15, 16). In the case of adenovirus, the early
events of infection such as cell attachment and internalization have
been partially defined (17-20), but little is known about the
transport of adenovirus DNA into the nucleus. As adenovirus is a strong
candidate for gene therapy applications (21), it is important to obtain
a detailed understanding of the interactions between this virus and the
host cell.
Adenovirus is a non-enveloped double-stranded DNA virus containing
11-15 different virus-encoded polypeptides and a linear genome of
~36 kilobase pairs (22). The total mass of the nucleocapsid is
estimated to be 150 MDa (22). The major capsid protein is the hexon
coat protein. The capsid contains 240 hexon trimers, which form an
icosahedron with 12 vertices and 20 facets. At the vertices are the
fiber proteins, which contain a primary cell-surface attachment site
(17). Anchoring each fiber to the capsid is the penton protein, which
contains a secondary binding site whose recognition is a precursor to
internalization (18, 19). Stabilizing the capsid are several other
minor proteins that either associate with hexons alone (proteins VI,
VIII, and IX) or strengthen the association between hexon and penton
proteins (proteins IIIa and IX). The DNA is condensed with proteins V,
VII, and µ and the covalently attached terminal protein, which
together form the viral core.
The adenovirus capsid is a very stable structure that protects the
viral genome against harsh environmental conditions. The virus enters
the cell by receptor-mediated internalization in coated pits, where the
combination of the energy of binding and the acidic environment of the
early endosome is thought to cause a series of cooperative structural
changes in the capsid (20). These structural changes appear to
facilitate fusion with the endosomal membrane and penetration into the
cytoplasm (23) as well as potentiate the loss of certain capsid
proteins. By the time it is delivered to the cytoplasm, the virus loses
the fiber penton, peripentonal hexon proteins, and the
capsid-stabilizing proteins (proteins IIIa, VIII, and IX) (20). The
nucleocapsid resulting from these rearrangements docks with the NPC,
where it appears to undergo further disassembly, allowing its DNA to enter the nuclear interior (20). Because cellular nucleoprotein particles (e.g. messenger ribonucleoproteins) can be
transported through the NPC by the machinery that mediates protein
transport (4), adenovirus similarly might exploit the cellular nuclear protein import machinery for the import of its DNA into the nuclei of
infected cells.
Here we use a digitonin-permeabilized cell assay to analyze the
interaction of nucleocapsid derived from adenovirus type 2 with the NPC
and the transport of viral DNA into the nucleus. Our results indicate
that adenovirus DNA import utilizes components of the classical protein
import machinery and hsp/hsc70. Furthermore, our findings, in
conjunction with previous work, indicate that the major capsid protein
(hexon) has an important role in viral DNA import. Since recombinant
factors for classical NLS-mediated import are insufficient to support
adenovirus DNA import, additional components appear to be involved. We
discuss the possibility that these are involved in nucleocapsid
uncoating at the NPC.
Nuclear Import Assays--
The bovine serum albumin (BSA)-NLS
peptide conjugate used as a nuclear transport substrate and HeLa
cytosol were prepared as described previously (3). The nuclear protein
import assay was carried out as described (3), with the use of virus in place of the BSA-NLS conjugate at 0.1-10 viruses/pore (assuming 2000 NPCs/nucleus). For competition assays, transport substrate was prepared
as described above, omitting the conjugation with fluorescein
isothiocyanate, and used at up to 50 µM. The anti-hsp70 antibody SPA810 (Stressgen Biotech Corp., Victoria, British Columbia, Canada) was used at 50-100 µg/ml. Import was reconstituted with recombinant import factors using 200 nM importin- Immunofluorescence Detection of Nucleocapsids--
Import assays
were performed as described above using pH 6.4 buffer-treated
nucleocapsids. The latter were introduced into the import assay at a
ratio of five viruses/NPC, or ~10,000 plaque-forming units/cell,
assuming 2000 NPCs/cell. Estimates of virus number were taken from our
observation that 1 µg of virus equals 109 plaque-forming
units. Nucleocapsids treated with pH 6.4 buffer cannot be quantitated
via plaque assay since they no longer possess the fiber and penton
proteins necessary for attachment and endocytosis. After incubating the
permeabilized cells for 30 min with nucleocapsids and washing, cells
were fixed for 6 min in 4% formaldehyde in PBS and permeabilized in
1% Triton X-100 in PBS. The nucleocapsid was detected by either
monoclonal anti-hexon antibody 2HX (American Type Culture Collection)
or polyclonal anti-hexon antibody AB1056 (Chemicon International, Inc.,
Temecula, CA) diluted in PBS containing 2% BSA. Primary antibodies
were incubated on slides for 1 h at room temperature, washed, and
incubated with either anti-goat or anti-rabbit rhodamine-labeled
secondary antibody in PBS containing 2% BSA for 1 h at room temperature.
Preparation of Adenovirus--
A549 cells (American Type Culture
Collection) were grown to 80% confluency in T-150 flasks in
Dulbecco's modified Eagle's medium supplemented with 10% fetal calf
serum, 2 mM glutamine, 100 units/ml penicillin, and 0.1 mg/ml streptomycin at 37 °C and 5% CO2. Cells were
subsequently infected with adenovirus type 2 (American Type Culture
Collection) for 16 h. The medium was replaced with a double volume
of fresh medium. Between 48 and 60 h post-infection, when cells
became rounded and detached but not lysed, the cells were harvested by
centrifugation and resuspended in 1 ml of complete medium. To extract
virus, cells were freeze-thawed three times by alternately placing
tubes in dry ice/ethanol and a 37 °C incubator. Lysates were then
centrifuged at 14,000 × g to remove cell debris. The
resultant high titer stock was either stored at Isolation of Viral DNA for Hybridization Probe--
60 µg of
adenovirus in Tris-buffered saline was pelleted in a Beckman Airfuge.
The pellets were carefully washed with Tris-buffered saline and
repelleted. To disrupt the capsid coat, a solution of Tris/EDTA (pH
8.0), 0.1% SDS, and 60 µg/ml proteinase K (Calbiochem) was added to
each tube and allowed to incubate overnight at 50 °C. The next
morning, the samples were boiled for 10 min to inactivate the
proteinase K. Viral DNA was precipitated with 0.33 volume of 2 M ammonium acetate (pH 4.0) and 2.5 volumes of ethanol.
Pellets were washed and allowed to air-dry.
Purification of Hexon Protein--
Hexon protein was isolated
using the protocol of Waris and Halonen (15). HeLa cells were grown and
infected as described above. After ~48 h, cells were harvested and
washed twice with PBS. Cells were disrupted by freeze-thawing three
times in the presence of 1,1,2-trichlorotrifluoroethane (Freon 113, Aldrich). Cell debris was removed by centrifugation at 1000 × g for 30 min. The supernatant was harvested and centrifuged
at 100,000 × g for 30 min. The resulting supernatant
was passed over a Mono Q column (Amersham Pharmacia Biotech) and eluted
with a linear salt gradient of 0.0-0.5 M NaCl in bis-Tris
buffer (14). The peak hexon fractions were combined and size-selected
over a Superose 12 column in bis-Tris buffer containing 0.15 M NaCl. All samples were monitored by SDS-polyacrylamide gel electrophoresis.
Detection of Viral DNA Using in Situ
Hybridization--
Nonradioactive probes were generated using the
GENIUS SYSTEM® (Roche Molecular Biochemicals). 1 µg of DNA
consisting of either whole viral DNA or the hexon coding region alone
was used as a template to generate digoxigenin-incorporated DNA probes
~1 kilobase pair in length via random priming. The hybridization
solution consisted of 6× SSC, 45% formamide, 5× Denhardt's
solution, 10% dextran sulfate, and 100 µg/ml salmon sperm DNA (33).
Upon completion of an import assay, slides were fixed with 4%
formaldehyde in PBS for 6 min, washed, and then permeabilized with 1%
Triton X-100 in PBS and washed. The slides were immediately dehydrated
in cold 100% isopropyl alcohol. In this state, they could be stored
overnight at Association of Adenovirus Nucleocapsid with the Nuclear Envelope in
Permeabilized Cells--
We used a permeabilized HeLa cell assay that
was previously developed to study nuclear protein import (3) to analyze
the nuclear import of adenovirus DNA. The permeabilized cells permit the virus to pass directly into the cytosolic environment without prior
exposure to the interior of the endosome. To simulate the exposure of
the virus to the acidic environment of the endosome that occurs
in vivo during infection, we pretreated the virus used for
our in vitro assay with mildly acidic (pH 6.4) buffer (24).
Consistent with previous studies (25), this treatment resulted in a
near-quantitative removal of the penton base and fiber proteins, as
detected by SDS-polyacrylamide gel electrophoresis (data not shown),
whereas only a small fraction of hexon protein was lost (24).
The treated nucleocapsids were introduced into the permeabilized cell
assay at ratios ranging from 0.1 to 10 nucleocapsids/NPC. Samples were
incubated for 30 min at 30 °C in the presence or absence of cytosol,
and the location of nucleocapsids was analyzed by immunofluorescence
staining with anti-hexon antibodies. In the presence of cytosol, we
observed strong accumulation of hexon at the nuclear periphery (Fig.
1A). At low concentrations of
nucleocapsid, the staining resembled the punctate pattern obtained by
immunofluorescence staining with anti-NPC antibodies (data not shown).
At higher concentrations, the staining also localized to the nuclear
rim, although some signal was apparent both within the nucleus and in
the cytosol as well (Fig. 1A). In the absence of added
cytosol, either weak or no perinuclear staining was observed (data not shown). The weak perinuclear staining seen in some experiments may be
due to the influence of residual cell cytosol that persists after
permeabilization. To examine whether acid pretreatment of the virus was
necessary for hexon accumulation at the nuclear periphery, we compared
the staining pattern obtained by carrying out the assay with pH 6.4 buffer-treated virus and untreated virus. We detected no significant
difference between the two (data not shown). To see if hexon
accumulation at the nuclear rim was dependent on basic amino acid-type
NLSs, we performed the assay in the presence of a 50-fold excess of
BSA-NLS conjugate competitor. In this instance, the amount of
anti-hexon fluorescence at the nuclear envelope was greatly diminished
(Fig. 1B). Nuclear rim staining was also diminished
significantly by the presence of wheat germ agglutinin (WGA) (Fig.
1C), a lectin that binds to O-linked glycosylated proteins of the NPC and that is known to block the active import of
nuclear proteins (26, 27). This suggests that an interaction with an
O-linked glycoprotein of the NPC is required for
nucleocapsid accumulation at the nuclear rim.
The nuclear rim anti-hexon immunofluorescence staining is likely to be
derived from intact nucleocapsids. To verify that nucleocapsids were
indeed docking with the NPC under the conditions of our assay, samples
were processed for thin-section electron microscopy (28) after a 30-min
incubation (Fig. 2). Numerous examples
were seen where nucleocapsids appeared to be docked with the NPC (Fig.
2). This is consistent with a recent analysis of adenovirus infection in vivo that showed that the nucleocapsid remains intact in
the cytoplasm after release from endosomes and apparently does not disassemble until after prolonged contact with the NPC (29). Although
other experiments demonstrate that purified hexon trimers were
efficiently imported into the nucleus (see below), the majority of
anti-hexon immunofluorescence staining observed here was excluded from
the nuclear interior, suggesting that hexons are associated with
structures that are too large to be imported. Considered together, our
immunofluorescence and electron microscopic data indicate that the
permeabilized cell assay allows the binding of adenovirus nucleocapsids
to the NPC in a manner similar to that observed in vivo
after normal viral infection.
Import of Adenovirus DNA in Vitro--
After establishing that
nucleocapsids bound to the nuclear envelope under our assay conditions,
we next sought to determine if these conditions also supported the
import of adenovirus DNA into the nucleus. To detect viral DNA, samples
were fixed after various periods of incubation, and slides were
processed for in situ hybridization with anti-DNA probes
representing either part or all of the adenovirus genome. After 30 min
of incubation, a strong accumulation of viral DNA at the nuclear
envelope was seen, but little DNA was observed in the nucleus (data not
shown). We could not directly compare hexon and DNA localization in the
same samples due to the destruction of the hexon protein epitope by the
conditions required for in situ hybridization. However,
comparison of parallel assays revealed that the majority of viral DNA
as well as hexon protein accumulated at the NPC at this time point. In
contrast, when we performed the incubation for 45 or 60 min, we found
that a significant amount of viral DNA appeared in the nucleus (Fig.
3, A and E). As
observed with protein import, DNA import also was blocked by the
addition of WGA (Fig. 3B) and by excess BSA-NLS conjugate
(Fig. 3C). Furthermore, GTP Import of Purified Hexon Protein into the Nuclei of
Digitonin-permeabilized Cells--
The apparent involvement of some
components of the nuclear protein import machinery in the transport of
adenovirus DNA into the nucleus suggested that a protein of the
nucleocapsid could play a role in this process. The fiber, penton, and
hexon proteins are all known to enter the nucleus during the assembly
of new virions after viral DNA replication. However, because the hexon is the only major protein associated with the nucleocapsid after release from the endosome during infection and is exposed on the nucleocapsid surface, we considered it to be the most likely agent responsible for targeting to the NPC. Despite its known karyophilic properties, no NLS has yet been identified on the hexon. To investigate if the hexon has an intrinsic sequence that can target it to the nucleus in the absence of other viral components, we analyzed the
nuclear import of purified fluorescently labeled hexon trimers (320 kDa) in permeabilized cells. The labeled hexon strongly localized to
the nuclear interior within 10 min (Fig.
4A). Nuclear import of the
purified hexon protein as well as of a control BSA-NLS conjugate was
blocked by WGA (Fig. 4B). The nuclear accumulation of both
proteins was strongly diminished when the assay was performed at
0 °C or when cytosol was first depleted of ATP by treatment with
hexokinase/glucose, conditions that block NLS-mediated import (data not
shown). Furthermore, when cytosol was preincubated with GTP
To investigate whether the hexon enters the nucleus by a basic amino
acid-type NLS pathway, we introduced competing nonfluorescent BSA-NLS
conjugates into our import reactions at a range of concentrations known
to successfully compete for import of fluorescent BSA-NLS conjugates.
The presence of excess competitor strongly reduced the levels of import
observed (Fig. 4D). A BSA-peptide conjugate containing the
sequence of the SV40 T-antigen NLS synthesized in reverse order, which
is known to lack the capacity to direct import (3), competed poorly for
import (data not shown), confirming that the competition was specific.
These data show that the hexon protein is imported into the nucleus by
an NPC-mediated process utilizing a basic amino acid-type NLS. Thus,
the nuclear import characteristics of the hexon protein are consistent
with a role for this protein in mediating the binding of nucleocapsid
to the NPC.
Involvement of hsp/hsc70 and Other Factors in Hexon and DNA
Import--
Because hsp/hsc70 has been implicated both in the early
events of infection following adenovirus penetration of the endosome (31) and in nuclear import of some proteins (9), we examined its role
in hexon and viral DNA import. Cytosol and permeabilized cells were
preincubated with an anti-hsp70 antibody known to inhibit SV40
NLS-mediated import, and this system was tested for its capacity to
support the import of purified hexon. The import of hexon coat protein
into the nucleus was not detectably affected by the presence of
anti-hsp70 antibodies (Fig.
5B), which do reduce the
import of BSA conjugated with peptides containing the SV40 T-antigen NLS or the c-Myc NLS (data not shown). The specificity of the block was
demonstrated by preincubation of recombinant hsc70 with the anti-hsp70
antibody, which alleviated the block in import of SV40 and the c-Myc
NLS when added to cytosol during preincubation (data not shown). In
contrast to the absence of an effect of the anti-hsp70 antibody on the
import of the purified hexon protein, the antibody significantly
diminished the import of viral DNA as measured by in situ
hybridization (Fig. 5, C and D).
To more extensively analyze mechanisms for the import of adenovirus
DNA, we analyzed the ability of purified cytosolic factors to support
this process. Hexon or a control SV40 NLS conjugate was added to
permeabilized cells in the presence of transport buffer alone or in the
presence of the four cytosolic factors that can reconstitute basic
amino acid-type NLS-mediated import (importin-
To assess the role of these factors in the import of the viral DNA, we
incubated whole nucleocapsids and permeabilized cells either with the
four purified transport factors analyzed above or with cytosol and
compared the levels of DNA import. No significant DNA import was seen
with buffer alone (Fig. 7A) or
with the four transport factors (Fig. 7C). In contrast,
whole cytosol produced a significant intranuclear signal in the same
assay (Fig. 7B). Since hsc70 is required for the import of
adenovirus DNA but not of purified hexon, we added it to the purified
factors to see if it would restore viral DNA import in permeabilized
cells. The addition of hsc70 at levels comparable to those reported to
support nuclear import in vivo (9) gave no significant
import of viral DNA into the nucleus (Fig. 7D). The activity
of the hsc70 used in this experiment was verified in ATPase assays and
by its ability to support the release of clathrin from coated vesicles
(data not shown). Thus, hsc70, in conjunction with the factors that support NLS-mediated import, is not sufficient to restore the import of
viral DNA. This indicates that other cytosolic components are required
for adenovirus DNA import.
Here we describe an assay for the import of adenovirus DNA into
the nuclei of permeabilized HeLa cells. In this assay, a large amount
of nucleocapsid becomes associated with the NPC within 30 min, as
documented by both immunofluorescence staining and thin-section
electron microscopy. A significant amount of viral DNA is subsequently
imported into the nucleus by 45-60 min, as monitored by in
situ hybridization. We have used this assay to define the
requirements for adenovirus DNA import and to begin a mechanistic
analysis of this process. As discussed in detail below, our experiments
indicate that the docking of adenovirus to the NPC is a prerequisite
for DNA import and that docking (and possibly subsequent steps)
involves the hexon protein and components of the machinery for nuclear
import of proteins containing basic amino acid-type NLSs. Although we
could reconstitute adenovirus DNA import in vitro with
cytosol and demonstrated a requirement for hsp/hsc70, the four
classical nuclear protein import factors together with hsc70 are
insufficient to reconstitute viral DNA import in permeabilized cells.
Our results showing that WGA blocks the docking of adenovirus at the
NPC and the internalization of viral DNA are consistent with the
effects of WGA in vivo (29). Furthermore, our electron microscopic data showing that nucleocapsids dock directly at the NPC
prior to the appearance of adenovirus DNA in the nucleus closely resemble electron microscopic observations made for in vivo
adenovirus infection (34-36). Thus, our assay reflects some of the
basic features of adenovirus DNA import that have been described
previously with in vivo studies and is likely to be
physiologically relevant.
Nucleocapsid docking at the NPC appears to be a necessary precondition
for DNA import since blocking the association of nucleocapsid with the
nuclear envelope in vitro either with WGA or with an excess
of a protein conjugate containing a classical NLS also inhibits the
import of viral DNA into the nucleus. Further support for nucleocapsid
docking at the NPC as a requirement for DNA import is the finding that
the kinetics of DNA import in vitro (this study) and
in vivo (29) are significantly slower than the kinetics of
nucleocapsid binding at the NPC. This conclusion is also supported by
immunofluorescence localization experiments involving cells infected
with adenovirus that suggest that the DNA-associated protein VII (and
presumably the associated DNA) is released from the capsid only after
the nucleocapsid docks at the nuclear envelope (29).
A variety of data suggest that the hexon coat protein is the principal
targeting determinant for adenovirus binding to the nuclear envelope.
A priori, the fact that the hexon has karyophilic properties, as shown in our in vitro studies, and is the
major protein on the surface of the viral capsid both in our in
vitro assay and in vivo (22) implicates it as the
principal agent responsible for docking to the NPC. Further evidence
for this is the fact that excess basic amino acid-type NLSs
competitively inhibit the import of purified hexon protein as well as
the docking of the nucleocapsid to the NPC. It is unclear whether the
role of the hexon protein is simply to dock the nucleocapsid to the NPC
or to engage more distal components of the NLS-mediated import machinery for the import of the adenovirus DNA-protein complex into the
nucleus. Other candidate proteins for this second function are proteins
VII and V, which are associated with viral DNA in the nucleus and may
be co-imported with the latter (29).
Although it is known that hexon trimers efficiently enter the nucleus
during viral assembly (36), an NLS on the hexon has not yet been
defined. However, scrutiny of the primary structure of the hexon
protein reveals several sequences that have basic amino acid-type NLS
character. One is at position 279 in the amino acid sequence, and
others occur at positions 567, 780, and 807. Although there are fewer
basic amino acids in each of these sequences than in the prototypical
NLS of the SV40 T-antigen, the amino acid sequence starting at position
279 shares at least a superficial similarity with a number of sequences
known to have NLS function (for a comprehensive list, see Ref. 37).
However, it must be pointed out that the hexon may not possess a
linear, continuous stretch of basic amino acids that serves as an NLS.
Instead, some of the sites mentioned above may combine in the folded
three-dimensional structure to form an active NLS. Finally, although
less likely, the hexon may altogether lack an intrinsic NLS, but could
rely on specifically binding to a host cytosolic protein that does possess an NLS.
Previous observations have suggested a role for hsp/hsc70 in the
infective pathway of adenovirus. Immunolocalization studies in infected
cells have shown that hexon protein and hsp/hsc70 associate after
release from the early endosome (31), raising the possibility that
hsp/hsc70 may act on the nucleocapsid before docking with the NPC. One
possible function of this binding could be to induce conformational
changes in the nucleocapsid that expose NLSs. Consistent with this
model, previous studies have shown that the hexon protein undergoes
conformational changes during uncoating (16). Although purified hexon
is imported into the nucleus and must therefore have an easily
accessible NLS, this signal may be concealed in the nucleocapsid until
a conformational change involving hsp/hsc70 or some other component
exposes it. It is tantalizing to speculate that the hexon in the intact
adenovirus nucleocapsid has a concealed NLS to protect the latter from
the host's immune system since most basic amino acid-type NLSs are charged, hydrophilic, exposed, and thus highly antigenic.
A second possible function for hsc70 could be to disassemble the
nucleocapsid at the NPC. Because capsid disassembly must occur before
viral DNA can be imported (20), it may be that this step is blocked by
the antibodies to hsp70. Docking with components of the NPC may
catalyze the conversion of nucleocapsid to a disassembled state, and
hsc70 could stabilize the disassembled state, consistent with its role
as a chaperone protein (38). Alternatively, hsp/hsc70 could actively
unfold the capsid. Finally, hsc70 may act directly on components of the
NPC itself, and it is their activity that is essential for the
translocation of viral DNA into the nucleus. In yeast, hsp/hsc70 has
been suggested to play a role in the binding of the NLS both to its
receptor and on the NPC itself during protein import (39). Our data do
not allow us to precisely identify the site of hsp/hsc70 activity in
the import pathway of adenovirus. It may be that hsp/hsc70 plays a role
in several steps in the infective pathway of adenovirus discussed above.
Permeabilized cell nuclear import assays similar to the one we describe
for adenovirus have been employed in the study of two lipid enveloped
viruses that replicate in the nuclei of infected cells: influenza virus
(12) and woodchuck hepadnavirus (40). A simple ribonucleoprotein
complex of influenza virus, consisting of nucleoprotein and the RNA
genome, is sufficient for the import of the influenza genome in
vitro and for the production of infectious virus in
vivo (12). Similarly, a complex of hepadnavirus DNA and viral
polymerase is sufficient to transport the hepadnavirus genome into the
nucleus in vitro (40). A combination of the cytosolic
factors that can reconstitute import of proteins with basic amino
acid-type NLSs in permeabilized cells is also sufficient to
reconstitute import of the influenza RNA in vitro (12).
Our work indicates that adenovirus requires a more complex set of
interactions with the host cell than these other viruses. In
particular, when the adenovirus nucleocapsid is introduced into a
permeabilized cell nuclear transport assay, a combination of the
cytosolic factors that support nuclear import of substrates with basic
amino acid-type NLSs together with hsc70 is insufficient to
reconstitute adenovirus DNA import, although DNA import is supported by
complete cytosol. The unknown cytosolic factors required for adenovirus
DNA import could be involved in nucleocapsid uncoating at the NPC
and/or in translocation through the pore. It is expected that the
in vitro assay reported here will permit detailed
biochemical analysis of these components, which are expected to be key
to adenovirus infectivity.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(also called the NLS receptor and
karyopherin-
), importin-
(also called p97 and karyopherin-
),
Ran (TC4), and NTF2 (also called p10 and pp15). An initial step in the
import of proteins containing classical NLSs occurs in the cytoplasm, where the substrate binds to the receptor importin-
. Subsequently, this complex docks at the cytoplasmic face of the NPC together with
importin-
. The complex is then translocated through a central gated
channel of the NPC into the nuclear interior. Movement of the import
complex through the NPC requires Ran and NTF2 (5-8), but the precise
role of these components is unclear. An additional protein, hsp/hsc70,
has been shown to be required for import of some substrates
(e.g. the large T-antigen protein (9)), but not of others
(e.g. the glucocorticoid receptor (10)).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, 200 nM importin-
, 1 µM NTF2, and 1 µM Ran with 1% BSA in transport buffer.
80 °C or
immediately utilized to purify virus by cesium chloride gradient
ultracentrifugation as described previously (21). The virus particle
was modified by treatment with pH 6.4 buffer as described by van
Oostrum and Burnett (24).
20 °C if necessary. Slides were then rehydrated
stepwise with 70, 50, and 30% EtOH in 6× SSC to a final hydrated
solution of 2× SSC. Cells were washed and then immersed in 0.1 N NaOH for 90 s at room temperature. Slides were again
washed in 2× SSC for 30 s and then dehydrated stepwise using the
solutions above. Slides were air-dried for 5 min. Prehybridization was
not routinely performed, as the background staining was low. Probe was
added to the hybridization fluid at a final concentration of 10 ng/10
µl, incubated for 10 min at 95 °C, and then plunged into slush-ice
to cool. Enough probe solution was added to cover the slide, and then a
coverslip was fixed in place. The entire slide was subsequently heated
to 95 °C for 10 min and then incubated from 6 h to overnight at
50 °C. After incubation, slides were washed with room temperature 6× SSC, followed by PBS. A 1:10 dilution of fluorescein
isothiocyanate-labeled anti-digoxigenin Fab fragments in PBS containing
1 mg/ml BSA was added and incubated at room temperature for 1 h.
Slides were washed for 5 min in PBS and examined by fluorescence
microscopy. For localization of adenovirus DNA with respect to the
nuclear lamina, slides were prepared as described above and incubated
with anti-lamin A/C antibody (guinea pig) for 1 h at room
temperature. Slides were then washed with PBS, incubated with Texas
Red-conjugated donkey anti-guinea pig IgG (Jackson ImmunoResearch
Laboratories, Inc.), mounted in Slofade® (Molecular Probes, Inc.,
Eugene, OR), and examined with a laser scanning confocal microscope
(MRC-1024, Bio-Rad).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (78K):
[in a new window]
Fig. 1.
Localization of hexon protein at the nuclear
envelope after incubation of adenovirus nucleocapsids with
permeabilized cells. Permeabilized HeLa cells were incubated for
30 min with cytosol and adenovirus nucleocapsids under various
conditions, washed, and analyzed by immunofluorescence staining with
the anti-hexon antibody. Although a strong nuclear rim staining can be
seen with cytosol alone (A), the addition of WGA
(B) or competing BSA-NLS conjugates (C) strongly
diminished hexon accumulation at the nuclear envelope.

View larger version (112K):
[in a new window]
Fig. 2.
Visualization of nucleocapsid binding to the
nuclear envelope in digitonin-permeabilized cells by electron
microscopy. Permeabilized cells were incubated with nucleocapsids
and cytosol for 30 min, washed and processed for thin-section electron
microscopy. Shown is a gallery of views of the nuclear envelope in
cross-section. NPCs are denoted by arrows.
S, an inhibitor of nuclear
protein import that interferes with the activity of Ran (5, 6) and
possibly of another GTPase (30), also blocked the import of viral DNA
(Fig. 3D). To confirm that the nuclear signal of viral DNA
observed by conventional microscopy (see above) corresponds to
intranuclear DNA and not simply DNA adsorbed to the nuclear surface, in
a separate experiment, slides were processed to detect both viral DNA
and nuclear lamins, which line the inner surface of the nuclear
envelope. Samples were examined by laser confocal microscopy taking
0.2-µm Z-sections through central regions of the nucleus;
a single section is shown in Fig. 3E. Viral DNA was clearly
localized in a number of intranuclear zones. In this particular
experiment, dense foci of viral DNA could be seen at or near the
cytosolic face of the nuclear envelope, presumably representing DNA
that had not yet been released from nucleocapsids. The abundance of
these foci varied considerably between different experiments. Taken
together, these data suggest that the import of adenovirus DNA into the
nuclei of permeabilized cells utilizes at least some of the components
involved in the nuclear import of NLS-bearing proteins.

View larger version (56K):
[in a new window]
Fig. 3.
Nuclear localization of adenovirus DNA during
nucleocapsid incubation with permeabilized cells is blocked by
inhibitors of NLS-mediated nuclear import. Permeabilized cells and
nucleocapsids were incubated for 1 h with cytosol alone
(A) or with cytosol supplemented with WGA (B),
competing BSA-NLS conjugates (C), or GTP
S (D).
Adenovirus DNA was detected by immunofluorescence microscopy after
in situ hybridization with a digoxigenin-labeled DNA probe,
and samples were viewed with conventional optics. In a separate
experiment, adenovirus DNA was visualized together with lamins using a
laser scanning confocal microscope (E).
S, both
hexon and control BSA-SV40 NLS failed to accumulate in the nucleus
(Fig. 4C). Under these conditions, the hexon protein appeared to become bound to cytoplasmic components, resulting in a
low-moderate level of cytoplasmic staining.

View larger version (87K):
[in a new window]
Fig. 4.
Purified adenovirus hexon protein is imported
into the nuclei of permeabilized cells by an NLS-mediated pathway.
Fluorescently labeled hexon trimers were added to permeabilized cells
and incubated for 30 min in the presence of cytosol alone
(A) or of cytosol supplemented with WGA (B),
GTP
S (C), or competing BSA-NLS conjugates (D).
Samples were visualized by fluorescence (Hexon) and
phase-contrast (Phase) microscopy.

View larger version (68K):
[in a new window]
Fig. 5.
Antibody against hsc70 blocks the import of
adenovirus DNA, but not of purified hexon protein. Nuclear import
of fluorescent hexon was undiminished by a 1-h preincubation at 0 °C
with an anti-hsc70 antibody (B) as compared with a control
sample lacking the antibody (A). Antibodies against hsc70
strongly inhibited the accumulation of viral DNA in the nucleus
(D) as compared with a control sample lacking the antibody
(C).
, importin-
, NTF2,
and Ran). In the absence of these exogenous import factors, there was
only a small amount of accumulation of signal in the nuclei of
permeabilized HeLa cells (Fig.
6A). This was probably due to
residual levels of factors not washed out after permeabilization.
However, with the added recombinant cytosolic transport factors, strong
accumulation of signal in the nucleus was seen both for the fluorescein
isothiocyanate-labeled hexon protein (Fig. 6B) and the
BSA-NLS conjugate (data not shown). Thus, as observed previously (32),
the four recombinant factors strongly stimulate
NLS-dependent nuclear protein import in permeabilized cells.

View larger version (78K):
[in a new window]
Fig. 6.
Purified import factors are sufficient to
support the nuclear import of purified hexon in permeabilized
cells. A mixture of recombinant importin-
, importin-
, Ran,
and NTF2 supported the import of BSA conjugated upon a 30-min
incubation with purified hexon (B), but transport buffer
without added import factors did not (A).

View larger version (90K):
[in a new window]
Fig. 7.
Purified protein import factors and hsc70 are
not sufficient to support the import of viral DNA. Nucleocapsids
were incubated with permeabilized cells for 1 h in the presence of
buffer alone (A); cytosol (B); buffer
supplemented with a mixture of importin-
, importin-
, Ran, and
NTF2 (C); or buffer supplemented with a mixture of
importin-
, importin-
, Ran, NTF2, and hsc70 (D). Buffer
alone (A) and buffer supplemented with the import factors
importin-
, importin-
, Ran, and NTF2 (C) did not
support the import of viral DNA. The addition of hsc70 to the factor
mixture did not significantly increase the level of viral import
observed (D).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Patricia Mathius, Dr. Dan Von Seggern, and Rod Endo for supplies of virus, help, and stimulating discussions. We thank Dr. Sandra Schmid for the donation of hsc70. In addition, we thank Dr. Frauke Melchior and Dr. Bryce Paschal for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants GM41955 (to L. G.) and HL54352 and EI38948 (to G. R. N.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Depts. of Cell and
Molecular Biology, Scripps Research Inst., 10550 N. Torrey Pines Rd.,
IMM 10, La Jolla, CA 92037. Tel.: 619-784-8514; Fax: 619-784-9132;
E-mail: lgerace@scripps.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
NPCs, nuclear pore
complexes;
NLS, nuclear localization sequence;
BSA, bovine serum
albumin;
PBS, phosphate-buffered saline;
bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol;
WGA, wheat germ agglutinin;
GTP
S, guanosine
5'-O-(3-thiotriphosphate).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Pollard, V. W., Michael, W. M., Nakielny, S., Siomi, M. C., Wang, F., and Dreyfuss, G. (1996) Cell 86, 985-994[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Standiford, D. M.,
and Richter, J. D.
(1992)
J. Cell Biol.
118,
991-1002 |
| 3. |
Adam, S. A.,
Marr, R. S.,
and Gerace, L.
(1990)
J. Cell Biol.
111,
807-816 |
| 4. | Nigg, E. A. (1997) Nature 386, 779-787[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Melchior, F.,
Paschal, B.,
Evans, J.,
and Gerace, L.
(1993)
J. Cell Biol.
123,
1649-1659 |
| 6. | Moore, M. S., and Blobel, G. (1993) Nature 365, 661-663[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Paschal, B. M.,
Delphin, C.,
and Gerace, L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7679-7683 |
| 8. | Clarkson, W. D., Corbett, A. H., Paschal, B. M., Kent, H. M., McCoy, A. J., Gerace, L., Silver, P. A., and Stewart, M. (1997) J. Mol. Biol. 272, 716-730[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Shi, Y.,
and Thomas, J. O.
(1992)
Mol. Cell. Biol.
12,
2186-2192 |
| 10. |
Yang, J.,
and DeFranco, D. B.
(1994)
Mol. Cell. Biol.
14,
5088-5098 |
| 11. | Gerace, L. (1992) Curr. Opin. Cell Biol. 4, 637-645[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
O'Neill, R. E.,
Jaskunas, R.,
Blobel, G.,
Palese, P.,
and Moroianu, J.
(1995)
J. Biol. Chem.
270,
22701-22704 |
| 13. | Gallay, P., Stitt, V., Mundy, C., Oettinger, M., and Trono, D. (1996) J. Virol. 70, 1027-1032[Abstract] |
| 14. |
Yamada, M.,
and Kasamatsu, H.
(1993)
J. Virol.
67,
119-130 |
| 15. | Waris, M., and Halonen, P. (1987) J. Chromatogr. 397, 321-325[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Shenk, T. (1996) Fundamental Virology , pp. 979-1016, Lippincott-Raven, New York |
| 17. |
Bergelson, J. M.,
Cunningham, J. A.,
Droguett, G.,
Kurt-Jones, E. A.,
Krithivas, A.,
Hong, J. S.,
Horwitz, M. S.,
Crowell, R. L.,
and Finberg, R. W.
(1997)
Science
275,
1320-1323 |
| 18. | Wickham, T. J., Mathius, P., Cheresh, D. A., and Nemerow, G. R. (1993) Cell 73, 309-319[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Wickham, T. J.,
Filardo, E. J.,
Cheresh, D. A.,
and Nemerow, G. R.
(1994)
J. Cell Biol.
127,
257-264 |
| 20. | Greber, U. F., Willetts, M., Webster, P., and Helenius, A. (1993) Cell 75, 477-486[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Robbins, P. D., Tahara, H., and Ghivizzani, S. C. (1998) Trends Biotechnol. 16, 35-40[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Stewart, P. L., Fuller, S. D., and Burnett, R. M. (1993) EMBO J. 12, 2589-2599[Medline] [Order article via Infotrieve] |
| 23. | Patterson, S., and Oxford, J. S. (1986) Vaccine 4, 79-90[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
van Oostrum, J.,
and Burnett, R.
(1985)
J. Virol.
56,
439-448 |
| 25. | Laver, W. G., Wrigley, N. G., and Pereira, H. G. (1969) Virology 39, 599-605[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Yoneda, Y., Imamoto-Sonobe, N., Yamaizumi, M., and Uchida, T. (1987) Exp. Cell Res. 173, 586-595[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Finlay, D. R.,
Newmeyer, D. D.,
Price, T. M.,
and Forbes, D. J.
(1987)
J. Cell Biol.
104,
189-200 |
| 28. | Guan, T., Muller, S., Klier, G., Pante, N., Blevitt, J. M., Haner, M., Paschal, B., Aebi, U., and Gerace, L. (1995) Mol. Biol. Cell 6, 1591-1603[Abstract] |
| 29. | Greber, U. F., Suomalainen, M., Stidwill, R. P., Boucke, K., Ebersold, M. W., and Helenius, A. (1997) EMBO J. 16, 5998-6007[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Sweet, D. J.,
and Gerace, L.
(1996)
J. Cell Biol.
133,
971-983 |
| 31. | Niewiarowska, J., D'Halluin, J. C., and Belin, M. T. (1992) Exp. Cell Res. 201, 408-416[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Dingwall, C., and Palacios, I. (1998) Methods Cell Biol. 53, 517-543[Medline] [Order article via Infotrieve] |
| 33. |
Langer-Safer, P. R.,
Levine, M.,
and Ward, D. C.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
4381-4385 |
| 34. | Dales, S., and Chardonnet, Y. (1973) Virology 56, 465-483[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Puvion-Dutilleul, F., and Puvion, E. (1995) Microsc. Res. Tech. 31, 22-43[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Cepko, C. L., and Sharp, P. A. (1982) Cell 31, 407-415[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Boulikas, T. (1993) Crit. Rev. Eukaryotic Gene Expression 3, 193-227[Medline] [Order article via Infotrieve] |
| 38. | Hartl, F. U. (1996) Nature 381, 571-579[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Shulga, N.,
Roberts, P.,
Gu, Z.,
Spitz, L.,
Tabb, M. M.,
Nomura, M.,
and Goldfarb, D. S.
(1996)
J. Cell Biol.
135,
329-339 |
| 40. | Kann, M., Bischof, A., and Gerlich, W. H. (1997) J. Virol. 71, 1310-1316[Abstract] |
This article has been cited by other articles:
![]() |
J. G. Smith, A. Cassany, L. Gerace, R. Ralston, and G. R. Nemerow Neutralizing Antibody Blocks Adenovirus Infection by Arresting Microtubule-Dependent Cytoplasmic Transport J. Virol., July 1, 2008; 82(13): 6492 - 6500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Knappe, S. Bodevin, H.-C. Selinka, D. Spillmann, R. E. Streeck, X. S. Chen, U. Lindahl, and M. Sapp Surface-exposed Amino Acid Residues of HPV16 L1 Protein Mediating Interaction with Cell Surface Heparan Sulfate J. Biol. Chem., September 21, 2007; 282(38): 27913 - 27922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wodrich, A. Cassany, M. A. D'Angelo, T. Guan, G. Nemerow, and L. Gerace Adenovirus Core Protein pVII Is Translocated into the Nucleus by Multiple Import Receptor Pathways J. Virol., October 1, 2006; 80(19): 9608 - 9618. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Chromy, A. Oltman, P. A. Estes, and R. L. Garcea Chaperone-mediated in vitro disassembly of polyoma- and papillomaviruses. J. Virol., May 1, 2006; 80(10): 5086 - 5091. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Strunze, L. C. Trotman, K. Boucke, and U. F. Greber Nuclear Targeting of Adenovirus Type 2 Requires CRM1-mediated Nuclear Export Mol. Biol. Cell, June 1, 2005; 16(6): 2999 - 3009. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gurer, A. Hoglund, S. Hoglund, and J. Luban ATP{gamma}S Disrupts Human Immunodeficiency Virus Type 1 Virion Core Integrity J. Virol., May 1, 2005; 79(9): 5557 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Varghese, Y. Mikyas, P. L. Stewart, and R. Ralston Postentry Neutralization of Adenovirus Type 5 by an Antihexon Antibody J. Virol., November 15, 2004; 78(22): 12320 - 12332. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Florin, K. A. Becker, C. Sapp, C. Lambert, H. Sirma, M. Muller, R. E. Streeck, and M. Sapp Nuclear Translocation of Papillomavirus Minor Capsid Protein L2 Requires Hsc70 J. Virol., June 1, 2004; 78(11): 5546 - 5553. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Bailey, R. G. Crystal, and P. L. Leopold Association of Adenovirus with the Microtubule Organizing Center J. Virol., December 15, 2003; 77(24): 13275 - 13287. [Abstract] [Full Text] [PDF] |
||||
![]() |